Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility

Chiara Cadeddu, Maria Lucia Specchia, Gualtiero Ricciardi, Chiara De Waure, Francesco Di Nardo, Silvio Capizzi, Agostino Mancuso, S Capri, Mr Gualano, N Nicolotti, F Kheiraoui, A Sferrazza, G Avallone, G La Torre

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Nessuno
Original languageEnglish
Title of host publicationProceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Pages107
Number of pages1
Publication statusPublished - 2013
Event10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” - Seoul
Duration: 15 Jun 201319 Jun 2013

Conference

Conference10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
CitySeoul
Period15/6/1319/6/13

Keywords

  • Health Technology Assessment
  • Human-derived Urofollitropin
  • Infertility

Fingerprint

Dive into the research topics of 'Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility'. Together they form a unique fingerprint.

Cite this